• Product nameAnti-BRD8 antibody
    See all BRD8 primary antibodies
  • Description
    Rabbit polyclonal to BRD8
  • SpecificitySpecific to p120
  • Tested applicationsSuitable for: ICC/IF, IHC-P, WB, IPmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Rat, Rabbit, Horse, Guinea pig, Dog, Pig, Rhesus monkey, Gorilla, Opossum, Chinese Hamster, Elephant
  • Immunogen

    This information is considered to be commercially sensitive.

  • Positive control
    • Nuclear extract from HeLa cells.


Associated products


Our Abpromise guarantee covers the use of ab17969 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ICC/IF Use a concentration of 5 µg/ml.
IHC-P 1/500 - 1/2000. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
WB 1/10000 - 1/25000. Detects a band of approximately 170 kDa (predicted molecular weight: 138 kDa).
IP Use at 2-8 µg/mg of lysate.


  • RelevanceBRD8 may act as a coactivator during transcriptional activation by hormone-activated nuclear receptors (NR). Isoform 2 stimulates transcriptional activation by AR/DHTR, ESR1/NR3A1, RXRA/NR2B1 and THRB/ERBA2. At least isoform 1 and isoform 2 are components of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histone H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. It interacts with MYC and adenovirus E1A protein.
  • Cellular localizationNuclear
  • Database links
  • Alternative names
    • Bromodomain containing 8 antibody
    • p120 antibody
    • Skeletal muscle abundant protein antibody
    • Skeletal muscle abundant protein 2 antibody
    • SMAP antibody
    • SMAP2 antibody
    • Thyroid hormone receptor coactivating protein 120kDa antibody
    • Thyroid hormone receptor coactivating protein antibody
    see all

Anti-BRD8 antibody images

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human prostate carcinoma tissue labelling BRD8 with ab17969 at 1/1000 (1µg/ml). Detection: DAB.

  • Predicted band size : 138 kDa
    Detection of human BRD8 by Western Blot. Sample is nuclear
    extract (NE; 5, 15, and 50mcg) from HeLa cells.
  • ICC/IF image of ab17969 stained MCF7 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab17969, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

References for Anti-BRD8 antibody (ab17969)

This product has been referenced in:
  • Yamaguchi K  et al. C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer. Br J Cancer 102:325-31 (2010). WB, IP ; Human . Read more (PubMed: 20051959) »

See 1 Publication for this product

Product Wall

There has been a revision in the entry for this target on the swissprot home page.

The epitope recognized by ab17969 is found within isoform 2 according to the current version of Uniprot entry Q9H0E9.


Read More